The Uromigos Episode 60: Cora Sternberg Discusses AMG 160, Bispecific Antibody in Prostate Cancer

By The Uromigos - Last Updated: September 21, 2020

Dr. Cora Sternber and the Uromigos discuss AMG 160, a half-life extended (HLE) bispecific T-cell engager (BITE®) antibody construct, and the future of immunotherapy in CRPC.

Post Tags:Uromigos-ESMOUromigos-Prostate Cancer
Advertisement
Advertisement
Advertisement